BioCardia says Japan allows patent for Heart3D fusion imaging software

• BioCardia announced allowance of a Japanese patent covering its Heart3D Fusion Imaging software used for planning and real-time navigation during CardiAMP cell therapy procedures.
• Patent, titled “Target Site Selection, Entry, and Update with Automatic Remote Image Annotation,” adds intellectual property protection for Heart3D in Japan.
• Claims cover fusing preoperative 3D CT or MRI heart images with two orthogonal 2D images to generate a 3D model for procedure guidance and location recording.
• BioCardia said it is working toward submissions in Japan for CardiAMP cell therapy and Helix intramyocardial delivery system following consultations with Japanese regulators.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioCardia Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-013535), on April 28, 2026, and is solely responsible for the information contained therein.